RE-COVER Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism
- S Shulman, C Kearon, AK Kakkar
- N Engl J Med
Study Participants The study included 18 113 patients who were enrolled in 44 countries. Patients had to have atrial fibrillation documented on electrocardiogram, and have $ 1 increased risk factor for stroke, including previous stroke or transient ischemic attack, a left ventricular ejection fraction of , 40%, New York Heart Association class II or higher heart failure, and aged $ 75 years or aged 65 to 75 years with diabetes, hypertension, or coronary artery disease. Patients were followed for a median of 2 years.